Home | Partnership | Careers | Contact Us | Location Map | Sign In
   
 
   
 
 
 
Home >> Product > Essential Updates
E-mail this page Print this page
EMEA recommends restricted use of nimesulide-containing medicinal products
Dated : 21 September 2007
European Medicines Agency review concludes positive benefit-risk balance for non-selective NSAIDs
Dated : 24 October 2006
European Medicines Agency update on review of non-selective NSAIDs
Dated : 26 September 2006
Questions and Answers on the Review of Non-Selective NSAIDs -EMEA
Dated : 24 October 2006
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID)
Dated : 07 May 2004
European Medicines Agency concludes action on COX-2 inhibitors
Dated : 27 June 2005
Cardiovascular safety of  non-selective NSAIDs
Dated : 02 August 2005
No new safety concerns regarding cardiovascular and gastrointestinal safety and serious skin reactions with non-selective NSAIDs
Dated : 17 October 2005
EMEA Public statement on the suspension of the Marketing Authorization for BEXTRA (valdecoxib) In the European Union
Dated : 27 October 2005
Guideline on the Non-Clinical Documentation for  Mixed Marketing Authorization Applications
Dated : 13 October 2005
 
   
Home | Contact Us | Sitemap | Disclaimer | Privacy Policy Copyright © 2007 Panacea Biotec. All Rights Reserved.